Join the club for FREE to access the whole archive and other member benefits.

New evidence on reversing cognitive ageing in aged mice

EP2 receptor which causes inflammation & ageing was knocked down in a disease model

20-Jan-2021

Key points from article :

Excess inflammation is a problem in aging, contributing to atherosclerosis, cancer, and cognitive decline.

Older immune cells when corrected, decreased inflammation and restored cognitive function.

"To be able to reverse the pathology is an incredible sequence of events.” - Eyal Amiel, associate professor of medical laboratory science.

People who took nonsteroidal anti-inflammatory drugs had a decreased risk of Alzheimer’s disease.

COX-2 activation is the first step in the production of PGE2, which bind to EP2 and promote inflammation.

When exposed human macrophages to PGE2, the cells altered their metabolism.

“The result is that the cells are basically energy-depleted and they don’t work well,” - Andreasson, neurologist and researcher.

When treated with EP2 receptor inhibitors, energy production increased and cells expressed anti-inflammatory markers.

There aren’t any drugs that specifically block the EP2 receptor yet.

Research by Stanford School of Medicine published in the Journal Nature.

Mentioned in this article:

Click on resource name for more details.

Eyal Amiel

Associate professor at the University of Vermont.

Katrin Andreasson

Professor of Neurology at Stanford University Medical Center

Nature

Scientific journal covering research from a variety of academic disciplines, mostly in science and technology

Stanford University School of Medicine

Medical school that improves health through discoveries and innovation in health care, education and research

Topics mentioned on this page:
Inflammaging, Alzheimer's Disease